Bruker Corporation Raised FY23 Revenue Outlook To $2.88B-$2.91B Vs. $2.92B Estimate (Prior Outlook: $2.85B-$2.90B), Projects FY23 Adjusted EPS Of $2.48-$2.53 Vs. $2.55 Estimate
Portfolio Pulse from Benzinga Newsdesk
Bruker Corporation has updated its FY23 revenue outlook to $2.88B-$2.91B, slightly below the $2.92B estimate but higher than its previous forecast of $2.85B-$2.90B. The company also projects its FY23 adjusted EPS to be $2.48-$2.53, which is below the $2.55 estimate. Additionally, Bruker anticipates organic revenue growth of 11.5%-12.5%, a 150 basis points increase from its prior outlook.
February 13, 2024 | 12:17 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Bruker Corporation has raised its FY23 revenue outlook to $2.88B-$2.91B, from a previous range of $2.85B-$2.90B, and expects adjusted EPS of $2.48-$2.53, slightly below the $2.55 estimate. Organic revenue growth is also projected to increase.
While Bruker Corporation's updated revenue outlook shows an improvement from its previous forecast, it still falls slightly below the market estimate. The adjusted EPS projection is also below expectations. However, the increase in organic revenue growth projections indicates a positive trend in the company's operations. These mixed signals could lead to a neutral short-term impact on BRKR's stock price, as investors weigh the improved revenue outlook against the slightly disappointing EPS forecast.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100